1. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype. Issue 3 (3rd April 2021) Authors: Baretti, Marina; Karunasena, Enusha; Zahurak, Marianna; Walker, Rosalind; Zhao, Yang; Pisanic, Thomas R.; Wang, Tza‐Huei; Greten, Tim F.; Duffy, Austin G.; Gootjes, Elske; Meijer, Gerrit; Verheul, Henk M.W.; Ahuja, Nita; Herman, James G.; Azad, Nilofer S. Journal: Clinical and translational science Issue: Volume 14:Issue 3(2021) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer. (2nd February 2016) Authors: Rudek, Michelle A.; Dasari, Arvind; Laheru, Daniel; He, Ping; Jin, Runyan; Walker, Rosalind; Taylor, Gretchen E.; Jimeno, Antonio; Donehower, Ross C.; Hidalgo, Manuel; Messersmith, Wells A.; Purcell, W. Thomas Journal: Journal of clinical pharmacology Issue: Volume 56:Number 8(2016) Page Start: 966 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗